Nexalin Technology, Inc. (NXLIW)
USD 0.17
(20.14%)
USD 0.17
(20.14%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 5.78 Million USD | 57.4% |
| 2022 | 2.79 Million USD | -54.55% |
| 2021 | 6.14 Million USD | 76.86% |
| 2020 | 3.47 Million USD | 138.59% |
| 2019 | 1.45 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1 Million USD | 23.55% |
| 2024 Q1 | 816.81 Thousand USD | -32.93% |
| 2023 Q4 | 1.21 Million USD | -50.0% |
| 2023 FY | 4.39 Million USD | 57.4% |
| 2023 Q3 | 2.43 Million USD | 169.72% |
| 2023 Q2 | 903.02 Thousand USD | 12.47% |
| 2023 Q1 | 802.87 Thousand USD | 6.88% |
| 2022 Q2 | 736.35 Thousand USD | 12.87% |
| 2022 Q1 | 652.42 Thousand USD | 8.29% |
| 2022 FY | 2.79 Million USD | -54.55% |
| 2022 Q4 | 751.17 Thousand USD | 15.35% |
| 2022 Q3 | 651.21 Thousand USD | -11.56% |
| 2021 Q3 | 1.84 Million USD | -12.37% |
| 2021 FY | 6.14 Million USD | 76.86% |
| 2021 Q4 | 602.49 Thousand USD | -67.29% |
| 2021 Q2 | 2.1 Million USD | 31.84% |
| 2021 Q1 | 1.59 Million USD | 247.65% |
| 2020 Q2 | 1.15 Million USD | -0.0% |
| 2020 FY | 3.47 Million USD | 138.59% |
| 2020 Q4 | 458.63 Thousand USD | -40.29% |
| 2020 Q3 | 768.14 Thousand USD | -33.55% |
| 2020 Q1 | 1.15 Million USD | 0.0% |
| 2019 FY | 1.45 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | 48.491% |
| Cerus Corporation | 143.15 Million USD | 95.961% |
| OrthoPediatrics Corp. | 137.01 Million USD | 95.781% |
| PetVivo Holdings, Inc. | 11.36 Million USD | 49.112% |
| Talis Biomedical Corporation | 67.18 Million USD | 91.395% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 76.825% |
| Inogen, Inc. | 236.08 Million USD | 97.551% |
| Spectral AI, Inc. | 20.86 Million USD | 72.29% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 89.676% |
| CVRx, Inc. | 76.14 Million USD | 92.407% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -63.871% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | 53.708% |
| Orthofix Medical Inc. | 667.42 Million USD | 99.134% |
| Venus Concept Inc. | 80.47 Million USD | 92.816% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 89.782% |
| Bioventus Inc. | 409.91 Million USD | 98.59% |
| BrainsWay Ltd. | 28.01 Million USD | 79.366% |
| Envoy Medical, Inc. | 17.89 Million USD | 67.698% |
| electroCore, Inc. | 32.03 Million USD | 81.951% |
| IceCure Medical Ltd | 16.87 Million USD | 65.742% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 86.375% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 67.213% |
| MaxCyte, Inc. | 84.84 Million USD | 93.186% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | 53.42% |
| PAVmed Inc | 64.82 Million USD | 91.082% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 88.681% |
| RxSight, Inc. | 103.85 Million USD | 94.433% |
| Sight Sciences, Inc. | 126.44 Million USD | 95.428% |
| SI-BONE, Inc. | 156.35 Million USD | 96.302% |
| TELA Bio, Inc. | 84.18 Million USD | 93.133% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 91.748% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 97.157% |
| LivaNova PLC | 843.54 Million USD | 99.315% |
| 908 Devices Inc. | 68.08 Million USD | 91.508% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 98.805% |
| Nemaura Medical Inc. | 7.13 Million USD | 19.015% |
| NeuroPace, Inc. | 75.29 Million USD | 92.322% |
| LENSAR, Inc. | 33.33 Million USD | 82.657% |
| Apyx Medical Corporation | 51.01 Million USD | 88.668% |
| Cutera, Inc. | 197.72 Million USD | 97.076% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 76.67% |
| BioSig Technologies, Inc. | 28.53 Million USD | 79.736% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 96.981% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 83.967% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 99.309% |
| Axonics, Inc. | 270.2 Million USD | 97.86% |
| Outset Medical, Inc. | 198.77 Million USD | 97.091% |
| IRIDEX Corporation | 31.81 Million USD | 81.828% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 96.792% |
| IRadimed Corporation | 30.12 Million USD | 80.807% |
| Tivic Health Systems, Inc. | 8.53 Million USD | 32.239% |
| INVO Bioscience, Inc. | 7.85 Million USD | 26.383% |
| Telesis Bio, Inc. | 63.48 Million USD | 90.894% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 94.128% |
| Varex Imaging Corporation | 224.8 Million USD | 97.428% |
| Quipt Home Medical Corp. | 148.66 Million USD | 96.111% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 50.684% |
| Pulmonx Corporation | 112.68 Million USD | 94.87% |
| Dynatronics Corporation | 9.9 Million USD | 41.65% |
| Modular Medical, Inc. | 17.52 Million USD | 67.018% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 71.361% |
| Semler Scientific, Inc. | 38.94 Million USD | 85.155% |
| InMode Ltd. | 215.68 Million USD | 97.319% |
| Bruker Corporation | 1.07 Billion USD | 99.463% |
| Cytosorbents Corporation | 48.33 Million USD | 88.039% |
| DexCom, Inc. | 1.69 Billion USD | 99.658% |
| Align Technology, Inc. | 2.07 Billion USD | 99.722% |
| Viveve Medical, Inc. | 22.17 Million USD | 73.926% |
| ZimVie Inc. | 275.12 Million USD | 97.899% |
| Movano Inc. | 29.69 Million USD | 80.528% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 95.788% |
| Nexalin Technology, Inc. | 5.78 Million USD | 0.0% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -63.871% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 99.038% |
| Profound Medical Corp. | 33.6 Million USD | 82.795% |
| Insulet Corporation | 939.9 Million USD | 99.385% |
| enVVeno Medical Corporation | 25.23 Million USD | 77.093% |
| Surmodics, Inc. | 98.69 Million USD | 94.142% |
| iCAD, Inc. | 22.22 Million USD | 73.987% |
| Nuwellis, Inc. | 22.61 Million USD | 74.433% |
| Biotricity, Inc. | 17.18 Million USD | 66.357% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 98.703% |
| Aethlon Medical, Inc. | 12.27 Million USD | 52.911% |
| InspireMD, Inc. | 22.95 Million USD | 74.809% |
| PAVmed Inc. | 64.82 Million USD | 91.082% |
| BIOLASE, Inc. | 34.66 Million USD | 83.32% |
| Beyond Air, Inc. | 61.7 Million USD | 90.63% |
| FONAR Corporation | 28.6 Million USD | 79.789% |
| AxoGen, Inc. | 149.33 Million USD | 96.129% |
| Vivani Medical, Inc. | 26.96 Million USD | 78.56% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 96.735% |
| Inari Medical, Inc. | 448.59 Million USD | 98.711% |
| UFP Technologies, Inc. | 58.08 Million USD | 90.047% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -17.326% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | 8.498% |
| Tenon Medical, Inc. | 16.96 Million USD | 65.928% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | 21.8% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 86.891% |
| AdaptHealth Corp. | 1.07 Billion USD | 99.464% |
| Sintx Technologies, Inc. | 15.2 Million USD | 61.967% |
| NanoVibronix, Inc. | 4.97 Million USD | -16.255% |
| Quanterix Corporation | 118.1 Million USD | 95.105% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 50.684% |
| Sensus Healthcare, Inc. | 14.44 Million USD | 59.968% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 98.528% |
| TransMedics Group, Inc. | 182.82 Million USD | 96.838% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 79.4% |
| NeuroMetrix, Inc. | 11.09 Million USD | 47.911% |
| Hyperfine, Inc. | 52.87 Million USD | 89.065% |
| Establishment Labs Holdings Inc. | 172 Million USD | 96.639% |
| Biomerica, Inc. | 6.97 Million USD | 17.149% |
| Bone Biologics Corporation | 9.42 Million USD | 38.681% |
| AVITA Medical, Inc. | 80.77 Million USD | 92.843% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | 43.931% |
| Silk Road Medical, Inc | 186.35 Million USD | 96.898% |